"I hate the term Third World country and maybe if we produce 30 Merck-like companies in India then this nomenclature will be dropped," Dr Anji Reddy, founder and chairman of Dr Reddy's Laboratories (DRL), once said at a lecture in Mumbai. This was quite characteristic of the man who always believed Indian firms and R&D are world class and that India would one day emerge as a nucleus of drug discovery.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?